Table 4. Performance results from all optical imaging modalities for the salivary tumor cohort, separated by salivary gland group (average ± SEM). The best performing modality for each groups’ evaluation metrics is bolded.
Group | Imaging | AUC | Accuracy | Sensitivity | Specificity |
---|---|---|---|---|---|
Parotid (N = 3) | HSI | 0.92 ± 0.04 | 88 ± 4% | 90 ± 4% | 79 ± 7% |
Autofluorescence | 0.60 ± 0.30 | 87 ± 2% | 99 ± 1% | 26 ± 26% | |
2-NBDG Dye | 0.77 ± 0.12 | 87 ± 2% | 97 ± 3% | 31 ± 31% | |
Proflavin Dye | 0.64 ± 0.32 | 89 ± 2% | 96 ± 2% | 54 ± 27% | |
Gaussian-RGB | 0.66 ± 0.15 | 81 ± 5% | 97 ± 2% | 38 ± 24% | |
Human-Eye | 0.72 ± 0.02 | 78 ± 15% | 95 ± 5% | 35 ± 20% | |
Other Salivary (N = 3) | HSI | 0.59 ± 0.14 | 76 ± 12% | 55 ± 29% | 85 ± 15% |
Autofluorescence | 0.80 ± 0.14 | 84 ± 10% | 77 ± 13% | 85 ± 6% | |
2-NBDG Dye | 0.52 ± 0.08 | 76 ± 11% | 49 ± 28% | 84 ± 16% | |
Proflavin Dye | 0.62 ± 0.10 | 77 ± 11% | 60 ± 30% | 78 ± 22% | |
Gaussian-RGB | 0.45 ± 0.03 | 70 ± 10% | 62 ± 31% | 57 ± 43% | |
Human-Eye | 0.78 ± 0.15 | 84 ± 9% | 76 ± 12% | 87 ± 6% |